XML 19 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Total revenues $ 27,864 $ 33,459 $ 7,500
Cost of revenue 7,930 2,004 975
Gross profit 19,934 31,455 6,525
Operating expenses:      
Research and development expenses, net 24,810 34,472 30,648
Marketing and business development expenses 576 244 932
General and administrative expenses 9,439 9,731 10,319
Total operating expenses 34,825 44,447 41,899
Operating loss (14,891) (12,992) (35,374)
Financial and other income, net 5,182 3,208 1,738
Loss before taxes on income (9,709) (9,784) (33,636)
Income tax expenses (tax benefits) 4,522 8,970 58
Net loss $ (14,231) $ (18,754) $ (33,694)
Basic net loss per share $ (0.16) $ (0.21) $ (0.39)
Diluted net loss per share $ (0.16) $ (0.21) $ (0.39)
Unrealized gain arising during the period from marketable securities $ 9 $ 2 $ 0
Total comprehensive loss $ (14,222) $ (18,752) $ (33,694)
Weighted average number of ordinary shares used in computing basic net loss per share 89,528,031 87,633,298 86,555,628
Weighted average number of ordinary shares used in computing diluted net loss per share 89,528,031 87,633,298 86,555,628